AI Prescribing Needs a Clinician Veto to Manage Trust and Liability
The paper analyses the new US bill H.R. 238 and Utah’s prescription‑renewal pilot that authorize AI to prescribe drugs, and proposes a ‘clinician’s veto’ architecture requiring calibrated confidence scores, uncertainty type disclosure, and real‑time inferential transparency. A survey of 136 U.S. clinicians shows they would only accept autonomous prescribing if those safeguards are in place, tying liability to system designers.